PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|November 2, 2016
- Pharmaceutical Technology-11-02-2016
- Volume 40
- Issue 11
Workstations Allow for Continuous Control of Cell Culture Processes
The InvivO2 workstations range from Baker Ruskinn allow researchers to conduct cell culture processes under a continuously controlled, physiologically relevant atmosphere.
The InvivO2 workstations range from Baker Ruskinn allow researchers to conduct cell culture processes under a continuously controlled, physiologically relevant atmosphere. The workstations control temperature, carbon dioxide, humidity, and oxygen, all of which are critical for cell growth. The new range of workstations have three new models that include a modular design and removable front cover. The workstations also include a direct-hand access sleeve port system, a single-plate entry system for instant insertion or removal of plates, a 60-second purge cycle time, and internal HEPA filtration. The incorporated ICONIC gas mixing technology saves on bench space and delivers precision control over oxygen levels, using up to 40% less nitrogen than previous gas mixing technology, making it flexible for laboratories.
Articles in this issue
almost 10 years ago
The Human Factor in Inspectionsalmost 10 years ago
Application of QbD and QRM to Analytical Method Validationalmost 10 years ago
Biosimilars to Drive Modern Manufacturing Approachesalmost 10 years ago
Cleaning Validation in Continuous Manufacturingalmost 10 years ago
Lubrication in Continuous Tubular Powder Blendersalmost 10 years ago
Integrated Membrane for Single-Use Filtration Assembliesalmost 10 years ago
Dual-Shaft Mixers Provide Efficient Turnoveralmost 10 years ago
Biomolecule Separator Reduces Sample Absorptionalmost 10 years ago
Dissolution TestingRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.